Gou et al. (2020) found that inhibition of cardiomyocyte-derived Exo-miR-19a-3p promoted angiogenesis and improved cardiac function in mice with myocardial infarction by targeting HIF-1 α. Here, SETD2 is linked to myocardial infarction.